South Africa's parliament has voted for a new health insurance bill which will pave the way towards universal healthcare – at the expense of private care.
Ukraine has big plans to leverage the for-profit sector to rebuild its shattered health care system after the war. Oleksii Iaremenko, Head of Health Recovery at the Ukraine Ministry of Health is speaking at HBI 2023, June 19-21. Meanwhile we talk to fellow panelist Mark Hellowell, an academic at the University of Edinburgh who with the EBRD is sitting alongside Iaremenko on the Ukraine panel.
Hundreds of staff at UK government watchdog the Care Quality Commission (CQC) have voted for further industrial action amid an ongoing dispute over pay. A one-day strike took place last week on Monday, April 17 and another is expected to happen next week on Tuesday, May 2.
Australia-based fertility specialist Virtus Health has a new showpiece clinic in Copenhagen. HBI hears it is targeting both locals and medical tourists, and speaks to a source to find out more about the appeal of the Danish market.
Czechia-based fertility group FutureLife continues to expand in Spain with its latest acquisition. HBI chats with a European fertility operator to find out what is making the Spanish market appealing to investors.
The Irish government is set to fund fertility treatment for eligible patients for the first time. HBI speaks to an Ireland-based operator to find out more.
The UK Foreign and Commonwealth Office (FCO) has issued a travel warning following the deaths of 22 British nationals who sought medical treatment in Turkey. The country has recently seen a tsunami of patients taking the trip due to a failing NHS in England and the promise of more affordable cosmetic surgeries. HBI speaks to three Turkey-based analysts to understand whether the safeguarding concerns are warranted and what impact the warnings could have on the medical tourism industry.
The slump in healthcare listed stocks and downward valuations of private businesses are encouraging potential buyers to examine enticing European healthcare enterprises.
FutureLife, the Czech Republic-based fertility company, has entered Spain and Italy with its latest acquisition. Owned by PE companies CVC and Hartenberg holding, the group has acquired Institut Marquès (IM), an assisted reproduction company based in Barcelona with clinics in Spain and Italy.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
